Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.31 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.30 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.30 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
| ▸ | DRD2 | P14416 | 1/20 | 0.30 |
| ▸ | DRD1 | P21728 | 1/20 | 0.30 |
| ▸ | DRD4 | P21917 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | DRD3 | P35462 | 1/20 | 0.30 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23934667 | 0.94 | DRD3 (0.34) | IDO1PDGFRBHTR1ADRD2DRD1 | |
| SCHEMBL23934655 | 0.90 | IDO1 (0.37) | IDO1PDGFRBSCN9ADRD2DRD3 | |
| SCHEMBL23739656 | 0.87 | IDO1 (0.38) | IDO1POLBLMNA | |
| SCHEMBL23934723 | 0.86 | F10 (0.33) | HTR1ADRD2DRD1DRD4HTR2A | |
| SCHEMBL23739968 | 0.86 | IDO1 (0.37) | IDO1POLBLMNA | |
| SCHEMBL23934512 | 0.82 | IDO1 (0.39) | IDO1PDGFRBHTR1ADRD2DRD1 | |
| SCHEMBL23739830 | 0.80 | IDO1 (0.36) | IDO1POLBLMNA | |
| SCHEMBL23739667 | 0.79 | POLB (0.35) | POLBLMNA | |
| SCHEMBL24572202 | 0.79 | POLB (0.35) | POLBLMNA | |
| SCHEMBL23739521 | 0.78 | POLB (0.35) | POLBLMNAHTR2AHTR2CHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3896062-A1 | ISOINDOLINE COMPOUND, AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND APPLICATION OF ISOINDOLINE COMPOUND | Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) | 2021-10-20 | — | — | EP | disclosed |